efficacy of risperidone in ADHD
Not Applicable
- Conditions
- attention deficit/hyperactivity disorder.Disturbance of activity and attention
- Registration Number
- IRCT201211051743N10
- Lead Sponsor
- Research center for behavioral disorders and substance abuse, Hamadan University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Inclusion Criteria: Diagnosed as ADHD according to DSM-IV TR and conner's scale; Age between 6 to12years; No other psychiatric disorders along with ADHD; No other debilitating physical illness along with ADHD; IQ>70
Exclusion Criteria
Severe drug complication during the study; abnormal labratory tests (BC,NA,K,BS,BUN,CR,TSH,AST,ALT,PRL,TOT CHOL,LDL CHOL,HDL,CHOL,TG).
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement ADHD symptoms. Timepoint: first of the study and after 2nd,4th,6th and 8th week of the study. Method of measurement: Clinical Global Impression Scale and conner`s parents rating scale for ADHD.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: after 2nd,4th,6th and 8th week of the study. Method of measurement: Clinical Global Impression Scale.